Invesco Ltd. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$17,237,486
-11.8%
1,086,168
+4.9%
0.01%0.0%
Q2 2023$19,543,753
+2695.4%
1,035,705
+468.9%
0.01%
Q1 2023$699,142
+54.8%
182,068
+99.9%
0.00%
Q4 2022$451,756
+3.4%
91,080
-0.4%
0.00%
Q3 2022$437,000
+12.3%
91,459
+5.9%
0.00%
Q2 2022$389,000
-3.2%
86,397
+2.5%
0.00%
Q1 2022$402,000
-35.6%
84,287
+0.3%
0.00%
Q4 2021$624,000
+19.1%
84,022
-8.9%
0.00%
Q3 2021$524,000
-0.9%
92,241
+15.0%
0.00%
Q2 2021$529,000
+33.9%
80,231
+64.5%
0.00%
Q1 2021$395,000
+40.6%
48,782
+12.1%
0.00%
Q4 2020$281,000
+146.5%
43,528
+37.5%
0.00%
Q3 2020$114,000
-98.2%
31,664
-97.7%
0.00%
-100.0%
Q2 2020$6,230,000
+8800.0%
1,354,400
+6593.0%
0.00%
Q1 2020$70,000
-96.6%
20,236
-95.0%
0.00%
-100.0%
Q4 2019$2,078,000
+4321.3%
407,014
+2262.0%
0.00%
Q1 2019$47,000
-42.0%
17,232
+2.3%
0.00%
Q4 2018$81,000
-57.6%
16,838
-16.3%
0.00%
Q3 2018$191,000
-92.1%
20,117
-91.9%
0.00%
-100.0%
Q2 2018$2,411,000
-76.6%
247,737
-74.7%
0.00%
-75.0%
Q1 2018$10,284,000
-0.4%
977,675
-39.3%
0.00%0.0%
Q4 2017$10,325,000
+42.2%
1,610,878
+69.7%
0.00%
+33.3%
Q3 2017$7,262,000
+203.7%
949,288
+182.4%
0.00%
+200.0%
Q2 2017$2,391,000
+4682.0%
336,186
+2522.4%
0.00%
Q1 2017$50,000
+127.3%
12,820
+20.1%
0.00%
Q4 2016$22,000
-99.7%
10,671
-98.9%
0.00%
-100.0%
Q1 2016$8,143,000
-29.0%
955,724
+13.1%
0.00%
-40.0%
Q4 2015$11,469,000
+23.8%
845,201
-12.4%
0.01%
+25.0%
Q3 2015$9,264,000
-61.0%
965,048
-41.5%
0.00%
-55.6%
Q2 2015$23,737,000
+140.9%
1,650,728
+77.4%
0.01%
+125.0%
Q3 2014$9,855,000
-10.0%
930,633
+26.9%
0.00%0.0%
Q1 2014$10,948,000
+35.6%
733,259
+33.3%
0.00%
+33.3%
Q4 2013$8,071,000
+18243.2%
550,227
+20973.4%
0.00%
Q3 2013$44,000
+2.3%
2,6110.0%0.00%
Q2 2013$43,0002,6110.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders